Relypsa, Inc. (RLYP) - NASDAQ
  • Alexander Valtsev | Send Message 17 Jun

    Biotech Beat - All Eyes On Relypsa Inc ($RLYP) And EXACT Sciences Corporation ($EXAS): http://bit.ly/160616EXAS
    Reply
      • Alexander Valtsev | Send Message 17 Jun

        $RLYP reported the May 2016 prescriptions for Veltassa. The following numbers are for May: http://bit.ly/160616RLYP
        Reply
          • timtrading | Send Message 16 Jun
            Reply
              • Bret Jensen | Send Message 16 Jun

                A Rebuttal To A Short Thesis On Relypsa $RLYP http://seekingalpha.com/a/2dcxe
                Reply
                  • wilkinson99 | Send Message 16 Jun

                    Premarket Top % Gainers: $PTX 38%, $QLGC 10%, $UVXY 8%, $GSS 8%, $TVIX 8%, $JNUG 5%, $GORO $RUSS $MUX $NUGT $EXAS $MGT $PPP $GIG $RLYP $HMY
                    Reply
                      • wilkinson99 | Send Message 16 Jun

                        Premarket Top % Gainers: $UVXY 9%, $TVIX 9%, $GEVO 8%, $JNUG 7%, $NUGT 6%, $RUSS 5%, $GPL $VIXY $VXX $IAG $AUDC $RLYP $BTG $EXK $KGC $GIG
                        Reply
                          • JKenser | Send Message 15 Jun

                            $RLYP. An SA editor has published a misleading headline on a stock and refuses to change it. Sad day. http://seekingalpha.com/c/175g34
                            Reply (1)
                            • JKenser | Send Message 15 Jun
                              : He claims that the stock opened down 4% after hours when clearly nasdaq states otherwise. http://tinyurl.com/hm2fmqr
                              • Alexander Valtsev | Send Message 14 Jun

                                Is Relypsa Headed To $9? Learn more: http://bit.ly/140616RLYP $RLYP
                                Reply
                                  • White Diamond Research | Send Message 14 Jun

                                    Why Relypsa Is Likely A Zero - The Chronic Hyperkalemia Treatment Market Is Small $RLYP http://seekingalpha.com/a/2dcec
                                    Reply
                                      • Abraxix | Send Message 8 Jun

                                        Put $LC profits into $RLYP
                                        Reply (1)
                                        • IndyPEG | Send Message 8 Jun
                                          : I like it
                                          Company Description
                                          Relypsa, Inc. operates as a bio-pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States